ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. lowered its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 1.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,340 shares of the company’s stock after selling 431 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in ARK Genomic Revolution ETF were worth $766,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. bought a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter valued at about $274,000. BKM Wealth Management LLC bought a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $78,000. International Assets Investment Management LLC grew its position in ARK Genomic Revolution ETF by 120.1% in the fourth quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock worth $3,280,000 after buying an additional 58,715 shares during the last quarter. Banque Pictet & Cie SA bought a new position in shares of ARK Genomic Revolution ETF in the third quarter valued at $264,000. Finally, Sweet Financial Partners LLC acquired a new stake in shares of ARK Genomic Revolution ETF during the 4th quarter valued at $525,000.

ARK Genomic Revolution ETF Price Performance

ARKG opened at $25.04 on Friday. The stock’s fifty day moving average is $27.40 and its two-hundred day moving average is $28.28.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.